Cluster 1: Health

  1. Inicio
  2. |
  3. Grant
  4. |
  5. Cluster 1: Health

European partnerships are initiatives in which the EU, together with public and private partners, commit to jointly support the development and implementation of a research programme and innovation activities in a particular area.

Cluster 1 is where the most competitive projects are included, the classic collaborative projects from previous Framework Programs and which bring together researchers, companies, research centers and universities.

Eligible actions

  • Personalized medicine.
  • Conditions of the environment on health and how we affect the environment.
  • Address the European Health Plan “One Health” against microbial resistance.

Partnerships

The Horizon Europe’s partnerships under Cluster 1 are:

  • Innovative Health Initiative
  • Global Health EDCTP3
  • Transformation of Health Care Systems
  • Risk Assessment of Chemicals
  • ERA for Health
  • Rare Diseases
  • One-Health Antimicrobial Resistance
  • Personalised Medicine
  • Pandemic Preparedness

Name

Opening date

Next deadline

Deadline model

Link

Financial support for Ecosystem Partners

16/08/2023

14/11/2023

single-stage

Safe & Sustainable by Design (SSbD) packaging and single use device solutions for healthcare products

27/07/2023

08/11/2023, 23/04/2024

two-stage

Sustainable circular development and manufacturing of healthcare products and their quantitative environmental impact assessment

27/07/2023

08/11/2023, 23/04/2024

two-stage

Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare

27/07/2023

08/11/2023, 23/04/2024

two-stage

Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment

27/07/2023

08/11/2023, 23/04/2024

two-stage

Inclusive clinical studies for equitable access to clinical research in Europe

27/07/2023

08/11/2023, 23/04/2024

two-stage

: Establishing novel approaches to improve clinical trials for rare and ultra-rare diseases

27/07/2023

08/11/2023, 23/04/2024

two-stage

Mission Ocean and Waters and Mission A Soil Deal for Europe – Joint demonstration of approaches and solutions to address nutrient pollution in the landscape-river-sea system in the Mediterranean sea basin

17 January 2023

20 Sep. 2023

single-stage

European Partnership on Rare Diseases

12 January 2023

19 Sep. 2023

single-stage

Mission Climate adaptation, Mission Ocean & waters and Mission Soil Deal for Europe – Joint demonstration of an integrated approach to increasing landscape water retention capacity at regional scale

17 January 2023

20 Sep. 2023

single-stage

Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society

30 March 2023

19 Sep. 2023

11 April 2024

two-stage

Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders

26 April 2023

19 Sep. 2023

11 April 2024 

two-stage

Tackling high-burden for patients, under-researched medical conditions

26 April 2023

19 Sep. 2023

two-stage

Access to health and care services for people in vulnerable situations

30 March 2023

19 Sep. 2023

11 April 2024

two-stage

Comparative effectiveness research for healthcare interventions in areas of high public health need

26 April 2023

19 Sep. 2023

two-stage

The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution

30 March 2023

19 Sep. 2023

11 April 2024

two-stage

Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness

26 April 2023

19 Sep. 2023

11 April 2024

two-stage

Innovative non-animal human-based tools and strategies for biomedical research

30 March 2023

19 Sep. 2023

11 April 2024

two-stage

Personalised prevention of non-communicable diseases – addressing areas of unmet needs using multiple data sources

30 March 2023

19 Sep. 2023

11 April 2024

two-stage

Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research

27 June 2023

28 Sep. 2023

03 April 2024

two-stage

Advancing point-of-care diagnostics to the market

27 June 2023

28 Sep. 2023

03 April 2024

two-stage

Scope: Europe

Budget: 8.246 M€

Organism: European comission

Aim of the project: R+D projects in the field of Health-

Any type of organization can apply for funding from Horizon Europe as long as it has the operational and financial capacity to carry out the tasks it proposes.

Direct and indirect costs.

Find out what they say about our work

Vaidas Palinauskas
Vaidas PalinauskasNature Research Centre
Read More
A perfect example of a 3 in 1 company: smooth process, professional and pleasant to work with.
Elena Casiraghi
Elena Casiraghi Università degli Studi di MIlano
Read More
Kindness, experience, ability to understanding and integrate different research languages/views.
Manuel Menéndez Muñiz
Manuel Menéndez MuñizVIAS
Read More
Very close team and well managed.
Jose Manuel Rodriguez
Jose Manuel RodriguezITAINNOVA
Read More
Well organized work, with filtered request to what really matters.
David Martín Gómez
David Martín Gómez- Charles III University of Madrid
Read More
I would like to point out that the elaboration of the proposal was steered with a lot of detail and efficiency.
Tania Tisheva
Tania TishevaBGRF
Read More
It was great meeting you and I am looking forward to working with you in the future. The professionalism of your team is excellent. I am very thankful for the guidance and cooperation during the whole process.
Alberta Aversa
Alberta AversaPolitecnico di Torino
Read More
cooperation rapid and effective.
Samuel Martínez
Samuel MartínezCircular in Motion B.V.
Read More
Excellent team in place which has been instrumental in assisting the creation of a robust application, which otherwise would have been very difficult for us to complete it. Their understanding of the process, deliverables required, and key areas to consider, is essential to increase the application success probability.
Daniel Edenholm
Daniel EdenholmSysarb AB
Read More
We would not have come this far without your help.
Fleming Pedersen Dambo
Fleming Pedersen DamboStaccato Technologies
Read More
I couldn't have done the application without the support from Euro-Funding Their expertise and guidance was invaluable.
Klas Ehnemark
Klas EhnemarkKnowing Company
Read More
Very positive to have strength in both business development and technology at the same time. Now we have a really good business plan.
Pablo Pérez
Pablo PérezAQUACORP
Read More
The experience of working with Euro-Funding has been both exciting and demanding because. The level of the consultants has been professional from an emotional intelligence and technical speaking perspective.
Manuel Grases
Manuel GrasesFlexofibers
Read More
I would recommend working with Euro-Funding. The level of professionalism is evident in the company. The process was exactly what we required.
Cristina Ferreras
Cristina FerrerasVenter Pharma
Read More
Euro-Funding helped us in a very professional and efficient way in all the steps of the preparation of the proposal. We consider the proposal to be of a very high standard. Without their help, we would not have been able to have the proposal in time and with such high quality.
Mátyás Péter
Mátyás PéterMedres Kft. / Cardiosight Ltd.
Read More
Despite a tight deadline, the team at Euro-Funding managed to accomplish the task and delivered an excellent grant proposal. It was a pleasure working with them.
Previous
Next